Intratumoral and peritumoral PET/CT-based radiomics for non-invasively and dynamically predicting immunotherapy response in NSCLC. Lin X, Liu Z, Zhou K, Li Y, et al. Br J Cancer 2025;132:558-568.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lin X, Liu Z, Zhou K, Li Y, et al. Intratumoral and peritumoral PET/CT-based radiomics for non-invasively and dynamically predicting immunotherapy response in NSCLC. Br J Cancer 2025;132:558-568.
PMID: 39930148